Contact Us | 1-800-343-7475
Learn how recent large-scale studies comprised of diverse cohorts are more representative of CFTR pathogenic variant frequencies in the broad U.S. population, compared to ethnically homogeneous data. A recently released PCR/CE based CFTR assay designed from ethnically diverse data can enable more equitable coverage with a simple workflow. Hear about Virginia Commonwealth University’s experience validating this assay and analysis software, along with their impression of the workflow.
© 2024 Asuragen, Inc. All rights reserved.